How can integrating different omics technologies help researchers better understand complex biological systems and advance drug discovery?

During ELRIG Drug Discovery 2026, Dr. Shi-qi An, Director of Marketing and Science Communications at Novogene Europe, spoke with News-Medical Life Sciences about the growing role of multiomics in modern biological research.

Drawing on her background in molecular microbiology and translational research, Dr. An discusses how combining genomics, transcriptomics, proteomics and metabolomics can provide deeper biological insights. The interview also explores emerging opportunities in single-cell and spatial omics, the importance of experimental design and bioinformatics, and the evolving needs of researchers across academia, biotechnology and pharmaceutical R&D.

These perspectives reflect Novogene Europe’s commitment to supporting researchers through integrated multiomics solutions, including applications in drug discovery and development.

Read the full interview on News-Medical Life Sciences